Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors. The Company's therapy treats solid tumors with interstitial radioactive seeds that continually release short-lived alpha-emitting atoms into the tumor.